Alnylam Pharmaceuticals, Inc.

ALNY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 6, 2026 PRIMARY DOCUMENT
144 Oct 2, 2026
4 Sep 22, 2026 PRIMARY DOCUMENT
10-Q Jul 30, 2026 10-Q
8-K Jul 30, 2026 8-K
4 Jun 3, 2026 PRIMARY DOCUMENT
4 Jun 3, 2026 PRIMARY DOCUMENT
3 Jun 3, 2026 PRIMARY DOCUMENT
144 Jun 1, 2026
8-K May 27, 2026 8-K
4 May 22, 2026 PRIMARY DOCUMENT
4 May 22, 2026 PRIMARY DOCUMENT
4 May 22, 2026 PRIMARY DOCUMENT
4 May 22, 2026 PRIMARY DOCUMENT
4 May 22, 2026 PRIMARY DOCUMENT
4 May 22, 2026 PRIMARY DOCUMENT
4 May 22, 2026 PRIMARY DOCUMENT
4 May 22, 2026 PRIMARY DOCUMENT
4 May 22, 2026 PRIMARY DOCUMENT
4 May 14, 2026 PRIMARY DOCUMENT
SCHEDULE 13G/A May 14, 2026
SCHEDULE 13G/A May 14, 2026
SCHEDULE 13G/A May 6, 2026
10-Q Apr 30, 2026 10-Q
8-K Apr 30, 2026 8-K
← Newer Page 1 of 68 · 1680 filings Older →